ACTIVATION OF HUMAN TONSIL LYMPHOCYTES BY RABIES VIRUS NUCLEOCAPSID SUPERANTIGEN

Citation
A. Martinezarends et al., ACTIVATION OF HUMAN TONSIL LYMPHOCYTES BY RABIES VIRUS NUCLEOCAPSID SUPERANTIGEN, Clinical immunology and immunopathology, 77(2), 1995, pp. 177-184
Citations number
27
Categorie Soggetti
Pathology,Immunology
ISSN journal
00901229
Volume
77
Issue
2
Year of publication
1995
Pages
177 - 184
Database
ISI
SICI code
0090-1229(1995)77:2<177:AOHTLB>2.0.ZU;2-I
Abstract
The capacity of the rabies virus superantigen (SAg) and the nucleocaps id (NC) to activate human tonsil lymphocytes was analyzed by studying the capacity of NC to cause lymphocytes to proliferate and secrete Ig and cytokines. NC activation was compared to that obtained with the St aphylococcus-derived SAg, SEE, and TSST-1. Despite a weak T lymphocyte mitogenic activity restricted to CD4(+) T cells, NC triggers tonsil B lymphocytes to produce IgG in quantities and frequencies similar to t hose of SEE and TSST-1. In the same way as these two SAg, NC induces I gG production only in the presence of T cells and optimally with a T/B ratio of 1/5. However, unlike SEE and TSST-1, NC does not trigger IgM production, The pattern of cytokines produced upon NC activation, IL- 4 and IL-10, weak IL-2 production, and no IFN-gamma, suggests that rab ies SAg stimulates Th2 rather than Th1 lymphocytes, In contrast, the p attern of cytokines produced upon TSST-1 activation, IL-2, IFN-gamma, and no IL-4, suggests that TSST-1 induces rather a Th1 response. The s pecific Th2 triggering by NC could explain the unique capacity of the rabies SAg to increase the in vivo antibody response to a simultaneous ly injected antigen. (C) 1995 Academic Press, Inc.